Huntington National Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $455 | Hold |
4
| – | – | ﹤0.01% | 2455 |
|
|
2025
Q1 | $420 | Sell |
4
-38
| -90% | -$3.99K | ﹤0.01% | 2490 |
|
|
2024
Q4 | $4.5K | Hold |
42
| – | – | ﹤0.01% | 2032 |
|
|
2024
Q3 | $4.2K | Hold |
42
| – | – | ﹤0.01% | 2047 |
|
|
2024
Q2 | $3.54K | Buy |
42
+3
| +8% | +$253 | ﹤0.01% | 2005 |
|
|
2024
Q1 | $2.85K | Hold |
39
| – | – | ﹤0.01% | 2057 |
|
|
2023
Q4 | $2.79K | Buy |
39
+38
| +3,800% | +$2.71K | ﹤0.01% | 2011 |
|
|
2023
Q3 | $60 | Sell |
1
-12
| -92% | -$720 | ﹤0.01% | 2567 |
|
|
2023
Q2 | $937 | Buy |
13
+12
| +1,200% | +$865 | ﹤0.01% | 2183 |
|
|
2023
Q1 | $74 | Hold |
1
| – | – | ﹤0.01% | 2291 |
|
|
2022
Q4 | $67 | Sell |
1
-1
| -50% | -$67 | ﹤0.01% | 2197 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2338 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2329 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2288 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2229 |
|
|
2020
Q4 | – | Sell |
-391
| Closed | -$23K | – | 1750 |
|
|
2020
Q3 | $23K | Buy |
391
+8
| +2% | +$471 | ﹤0.01% | 1003 |
|
|
2020
Q2 | $27K | Buy |
383
+151
| +65% | +$10.6K | ﹤0.01% | 933 |
|
|
2020
Q1 | $11K | Sell |
232
-106
| -31% | -$5.03K | ﹤0.01% | 1172 |
|
|
2019
Q4 | $22K | Sell |
338
-48
| -12% | -$3.12K | ﹤0.01% | 1222 |
|
|
2019
Q3 | $24K | Sell |
386
-74
| -16% | -$4.6K | ﹤0.01% | 1066 |
|
|
2019
Q2 | $33K | Buy |
460
+53
| +13% | +$3.8K | ﹤0.01% | 980 |
|
|
2019
Q1 | $32K | Buy |
407
+83
| +26% | +$6.53K | ﹤0.01% | 984 |
|
|
2018
Q4 | $27K | Buy |
324
+10
| +3% | +$833 | ﹤0.01% | 1046 |
|
|
2018
Q3 | $54K | Sell |
314
-24
| -7% | -$4.13K | ﹤0.01% | 928 |
|
|
2018
Q2 | $44K | Sell |
338
-104
| -24% | -$13.5K | ﹤0.01% | 984 |
|
|
2018
Q1 | $46K | Sell |
442
-172
| -28% | -$17.9K | ﹤0.01% | 977 |
|
|
2017
Q4 | $52K | Hold |
614
| – | – | ﹤0.01% | 964 |
|
|
2017
Q3 | $52K | Sell |
614
-29
| -5% | -$2.46K | ﹤0.01% | 963 |
|
|
2017
Q2 | $49K | Buy |
643
+167
| +35% | +$12.7K | ﹤0.01% | 950 |
|
|
2017
Q1 | $31K | Buy |
476
+5
| +1% | +$326 | ﹤0.01% | 993 |
|
|
2016
Q4 | $30K | Sell |
471
-10
| -2% | -$637 | ﹤0.01% | 1028 |
|
|
2016
Q3 | $31K | Buy |
481
+220
| +84% | +$14.2K | ﹤0.01% | 1029 |
|
|
2016
Q2 | $19K | Buy |
+261
| New | +$19K | ﹤0.01% | 1142 |
|
|
2016
Q1 | – | Sell |
-173
| Closed | -$12K | – | 1788 |
|
|
2015
Q4 | $12K | Buy |
+173
| New | +$12K | ﹤0.01% | 1335 |
|